Skip to main content
Annals of Intensive Care logoLink to Annals of Intensive Care
. 2022 Apr 1;12:30. doi: 10.1186/s13613-022-01007-7

Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients

Frank Bidar 1,2,3, Sarah Hamada 3, Morgane Gossez 3,4, Remy Coudereau 1,3, Jonathan Lopez 5, Marie-Angelique Cazalis 1, Claire Tardiveau 1, Karen Brengel-Pesce 1, Marine Mommert 1, Marielle Buisson 6, Filippo Conti 1, Thomas Rimmelé 1,2, Anne-Claire Lukaszewicz 1,2, Laurent Argaud 7, Martin Cour 7, Guillaume Monneret 1,3, Fabienne Venet 3,4,; RICO Study Group
PMCID: PMC8972669  PMID: 35362873

Correction to: Ann Intensive Care (2022) 12:21 https://doi.org/10.1186/s13613-022-00982-1

In the original publication of the article [1], the legends of x- and y-axis of panel a in Fig. 1 was inadvertently omitted. Figure 1 should have appeared as shown in this correction (Fig. 1).

Fig. 1.

Fig. 1

Transcriptomic profile of mononuclear cells in severe COVID-19 patients. RNA extracted from PBMCs of COVID-19 patients at day 0 and day 20 (n = 10) and healthy volunteers (HV, n = 10) was analyzed through NanoString technology. a Volcano plots of differentially expressed genes between patients sampled at D0 or at D20 and HV are showed. Limits of significance are illustrated by red dotted lines (i.e. Log2 Fold Change = −2 or + 2 and −Log 10 P value = 1.3). Selected genes are mentioned. b Venn diagrams of significantly up-regulated (left diagram, n = 21) or down-regulated (right diagram, n = 48) genes between patients and HV are showed. c Ingenuity Pathway Analysis was applied on the list of differentially expressed genes at D0 and D20. Heatmaps of Log 10 P-value (from white indicating the absence of significance to dark red indicating a strong significance) and Z-score (from orange indicating a down-regulation to purple indicating an up-regulation) for pathways related to T cell activation at D0 and D20 are presented

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Fabienne Venet, Email: fabienne.venet@chu-lyon.fr.

RICO Study Group:

Remi Pescarmona, Lorna Garnier, Christine Lombard, Magali Perret, Marine Villard, Sébastien Viel, Valérie Cheynet, Elisabeth Cerrato, Estelle Peronnet, Jean-François Llitjos, Laetitia Itah, Inesse Boussaha, Françoise Poitevin-Later, Christophe Malcus, Marine Godignon, Florent Wallet, Marie-Charlotte Delignette, Frederic Dailler, Marie Simon, Auguste Dargent, Pierre-Jean Bertrand, Neven Stevic, Marion Provent, Laurie Bignet, Valérie Cerro, Jean-Christophe Richard, Laurent Bitker, Mehdi Mezidi, and Loredana Baboi

Reference

  • 1.Bidar F, Hamada S, Gossez M, Coudereau R, Lopez J, Cazalis M-A, Tardiveau C, Brengel-Pesce K, Mommert M, Buisson M, Conti F, Rimmelé T, Lukaszewicz A-C, Argaud L, Cour M, Monneret G, Venet F. Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients, for the RICO study group. Ann Intensive Care. 2022;12:21. doi: 10.1186/s13613-022-00982-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Intensive Care are provided here courtesy of Springer-Verlag

RESOURCES